Stay updated on Filgotinib Combo in RA Patients Inadequate Response Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.

Latest updates to the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page
- Check4 days agoChange DetectedAdded funding metadata (2016 U.S. NIH Grant/Contract) and a related topics reference (MedlinePlus Genetics). Reaffirmed the study’s core condition (rheumatoid arthritis).SummaryDifference0.1%

- Check11 days agoChange DetectedRheumatoid arthritis and related topic links have been removed from the page, reducing the visible disease context and related information accessible from the page.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded PDFs for the Study Protocol and SAP, included IPD sharing information, and expanded related MeSH terms and topics relevant to the trial.SummaryDifference100%

- Check25 days agoChange DetectedKey documents such as Statistical Analysis Plan, Study Protocol, and IPD sharing information appear to have been removed from the study's Documents section. This change alters what users can review about the trial's methodology and data-sharing practices.SummaryDifference16%

- Check32 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a CMS/version update rather than any changes to the study details.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page shows a new Revision tag (v3.6.3) replacing the previous v3.6.0, indicating a small update to the page's underlying version, without altering the displayed study details.SummaryDifference0.0%

Stay in the know with updates to Filgotinib Combo in RA Patients Inadequate Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.